Literature DB >> 27466991

Upregulation of miR-522 is associated with poor outcome of hepatocellular carcinoma.

Y-H Shi1, B-B Qi, X-B Liu, H-M Ding.   

Abstract

OBJECTIVE: The aim of our study was to explore the clinicopathologic and prognostic significance of miR-522 expression in human hepatocellular carcinoma (HCC). PATIENTS AND METHODS: The expression of miR-522 in 161 HCC tissues and adjacent non-tumor tissues was examined using quantitative real-time-PCR. The association of miR-522 expression with clinicopathological features and the prognosis of HCC patients were also analyzed. The overall survival (OS) was analyzed by log-rank test. Cox regression models were fitted to analyze the effect of prognostic factors on OS.
RESULTS: The relative level of miR-522 was significantly higher in HCC tissues compared to the adjacent normal liver tissues. In addition, miR-522 upregulation more frequently occurred in HCC specimens with lymph node metastasis (p = 0.000), and tumor grade (p = 0.002). Moreover, the level of miR-522 expression was markedly correlated with the HCC patients' overall survival (p < 0.000). In the Cox proportional hazard model, the results showed that miR-522 overexpression was an independent prognostic factor for OS
CONCLUSIONS: Overexpression of miR-522 functions as an unfavorable prognostic biomarker in HCC patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27466991

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Physcion induces apoptosis in hepatocellular carcinoma by modulating miR-370.

Authors:  Xiaoping Pan; Haixia Wang; Dongmeng Tong; Chen Wang; Li Sun; Chunjuan Zhao; Yan Li; Lida Zhu; Di Wu
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma.

Authors:  Dengdi Hu; Dan Shen; Min Zhang; Nengmeng Jiang; Feng Sun; Shibo Yuan; Kaiming Wan
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

3.  Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.

Authors:  Yue Zhang; Chao Wei; Cong-Cong Guo; Rong-Xiu Bi; Jin Xie; Dong-Hui Guan; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-09-14

4.  CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.

Authors:  Haiyang Zhang; Ting Deng; Rui Liu; Tao Ning; Haiou Yang; Dongying Liu; Qiumo Zhang; Dan Lin; Shaohua Ge; Ming Bai; Xinyi Wang; Le Zhang; Hongli Li; Yuchong Yang; Zhi Ji; Hailong Wang; Guoguang Ying; Yi Ba
Journal:  Mol Cancer       Date:  2020-02-27       Impact factor: 27.401

5.  A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes.

Authors:  Xiaoming Dai; Ruixue Huang; Sai Hu; Yao Zhou; Xiaoya Sun; Pucheng Gui; Zijian Yu; Pingkun Zhou
Journal:  Cell Biosci       Date:  2020-02-27       Impact factor: 7.133

6.  Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522.

Authors:  Hong-Gang Qian; Qiong Wu; Jian-Hui Wu; Xiu-Yun Tian; Wei Xu; Chun-Yi Hao
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

7.  The SNP rs4846048 of MTHFR enhances the cervical cancer risk through association with miR-522: A preliminary report.

Authors:  Xinyue Zhou; Lili Shan; Jing Na; Ya Li; Jun Wang
Journal:  Mol Genet Genomic Med       Date:  2019-11-21       Impact factor: 2.183

8.  Targeting of ΔNp63α by miR-522 promotes the migration of breast epithelial cells.

Authors:  Yuanyuan Dong; Juan Long; Xingyong Luo; Gang Xie; Zhi-Xiong Jim Xiao; Ying Tong
Journal:  FEBS Open Bio       Date:  2021-01-10       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.